PEDMARK® REDUCED THE RISK OF CISPLATIN-INDUCED OTOTOXICITY IN PEDIATRIC PATIENTS WITH HEPATOBLASTOMA, SEEN IN A TURKISH COMPASSIONATE USE TREATMENT PROTOCOL için istatistikler

Toplam ziyaret

views
PEDMARK® REDUCED THE RISK OF CISPLATIN-INDUCED OTOTOXICITY IN PEDIATRIC PATIENTS WITH HEPATOBLASTOMA, SEEN IN A TURKISH COMPASSIONATE USE TREATMENT PROTOCOL 0

Aylık toplam ziyaret

views
Ocak 2025 0
Şubat 2025 0
Mart 2025 0
Nisan 2025 0
Mayıs 2025 0
Haziran 2025 0
Temmuz 2025 0